menu close
www.drenbio.com/

Dren Bio Stock

Company Profile:

Dren Bio is developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents. Dren’s lead programs are initially focused on hematologic neoplasms and solid cancers. Dren is actively working in other areas including auto-immune disorders and diseases of protein aggregation.

Sign up for SecondMarket™ to view the market and buy or sell Dren Bio Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Dren Bio Management Team

  • Founder, CEO, Director

    Nenad Tomasevic

  • Director

    Andrew Schiff

  • Director

    Chandra P. Leo

  • Director

    Rajeev Dadoo

  • Director

    Sakae Asanuma

  • Chief Medical Officer

    Matthias Will

  • Director

    Alex Kolicich

Dren Bio Major Investors

  • Taiho Ventures, LLC

  • ArrowMark Partners

  • Revelation Partners

  • BVF Partners LP

  • Alexandria Venture Investments

  • 8VC

  • Mission BioCapital

  • SR One Ltd

  • Pfizer Inc.

  • HBM Healthcare Investments AG

  • Aisling Capital LLC

Learn More About Dren Bio Stock

Buy Dren Bio Stock
01

Dren Bio stock does not trade on public stock exchanges. Dren Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Dren Bio stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Dren Bio Stock
02

Dren Bio Stock does not trade on public stock exchanges. In order to sell Dren Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Dren Bio Stock Price
03

Dren Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Dren Bio share price and other valuable private market data.

Read more about secondary market private company stock prices:

Dren Bio Stock Ticker Symbol
04

There is no ticker symbol for Dren Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Dren Bio Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Dren Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Dren Bio Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Dren Bio stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Dren Bio Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Dren Bio IPO
08

Dren Bio is a private company and has not had an IPO. There is currently no Dren Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Dren Bio IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Dren Bio Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Health

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Click Therapeutics

Biotechnology company that develops, validates, and commercializes software as prescription medical treatments

TurtleTree

Biotech company focused on creating sustainable and innovative nutrition solutions.

NewLimit-Logo

NewLimit

Develops epigenetic reprogramming therapies.

Source: Nasdaq Private Market Tape D™